Schellenberg Wittmer advised OC Oerlikon as the Freienbach-based surface technologies specialist placed CHF 350 million in dual-tranche senior unsecured bonds. The placement The operation features two tranches, respectively of CHF 150 million 1.375% bonds due in 2028 and CHF 200
Zurich-based media production company Ringier has integrated data protection and compliance into the legal department led by Manuel Liatowitsch, Group General Counsel, CLO & head of Corporate Center as well as member of the Group
Homburger advised UBS Group on the issuance of €2 billion in fixed-rate, fixed-rate callable senior notes under its Senior Debt Programme. The issuance The operation was split into two tranches: €1.25 billion maturing in 2036 and €750 million maturing
Baker McKenzie advised Deka Immobilien throughout the acquisition of its first real estate logistics investment in the Swiss canton of Ticino, completed for the company’s open-ended real estate fund WestInvest InterSelect. Erected in 2013, the
Kellerhals Carrard advised Ricola throughout its latest product expansion, leading to the launch of the Ricola Drink Cubes. The new product has been developed in collaboration with Waterdrop, an Austrian hydration brand in which Ricola
Winterthur-based Rieter – a globally active supplier of systems for manufacturing yarn – has closed a CHF 750 million syndicated financing. The syndicate behind the operation included UBS Switzerland and Zürcher Kantonalbank, as well as a group
Zurich-based Thouvenin advised Global Group on the acquisition of Swiss Quality Broker, an insurance broker with headquarters in Pfaffikon and active across the country. The Thouvenin team The Thouvenin lineup working on the matter included
Lenz & Staehelin advised software and cloud solutions provider SoftwareOne throughout closing of a CHF 1.26 billion syndicated financing, with Niederer Kraft Frey representing the lenders. The syndicate arranging the operation included BNP Paribas, UBS Switzerland,
Lenz & Staehelin represented Samsung Bioepis – part of the Samsung Bioepis group, the developer of the biosimilar Pyzchiva – in a patent nullity proceedings before the Swiss Federal Patent Court. On 12 August 2025, the Court upheld a
KKCG sold a 4.27% stake in Allwyn to J&T Arch Investments Sicav, an investor fund listed on the Prague Stock Exchange. In connection with the deal, Schellenberg Wittmer – alongside A&O Shearman – advised
